TS-121

· Taisho Pharmaceutical R&D Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TS-121, covering 2017-02-14 to 2019-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder [Phase 2]

See pricing